Don’t Write Actemra Off Yet: Roche Drug Found To Be Lifesaving In COVID-19
Shown To Cut Deaths By 8%
After failing in five earlier trials, Actemra shows significant life-saving benefits for patients with severe COVID-19.
You may also be interested in...
GSK Antibody Appears Effective In Older COVID-19 Patients
With elderly patients disproportionately facing hospitalization and death from COVID-19, success in the clinic would create an important market for the drug.
Coronavirus Update: South Korean Nod For AZ/Oxford Vaccine, Actemra Progesses In Japan
South Korea approves AstraZeneca’s COVID-19 Vaccine, while Actemra moves forward in Japan after local study results.
More Good News On Actemra In Severe COVID-19 – But Will Roche File For Approval?
The RECOVERY trial has found Actemra to help cut deaths and speed recovery – and UK doctors are not waiting for Roche to complete its own studies.